RxDoctor Payments DataLook up a doctor →

Samuel Tyagi, MD

Vascular Surgery · Lexington, KYNPI 1053638734

Payments from drug & device makers

$153,342in general payments, 2019–2025

Across 566 payments — averaging $270.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$75K
  • Penumbra, Inc.$33K
  • Bard Peripheral Vascular, Inc.$10K
  • Cook Medical LLC$9K
  • W. L. Gore & Associates, Inc.$7K
  • Cook Incorporated$6K
  • plus $13K from 18 others

What the payments were for

  • Consulting fees$3,6405%
  • Speaking & faculty fees$8,10012%
  • Travel & lodging$21,91931%
  • Food & beverage$35,71951%
  • Education$4771%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$153,342 in reported general payments places this provider in the 95th percentile of 72 vascular surgery providers in Kentucky.

See all vascular surgery providers in Kentucky

Medicare billing

Part B allowed, 2024
$76,220
Medicare patients
309
Services billed
529

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
ClopidogrelClopidogrel Bisulfate21$147

Paid to pharmacies, not to this prescriber.

Other vascular surgery in Lexington

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →